Thomas R Payne

Title: Thomas R. Payne: Innovator in Immunotherapy and Cell Cryopreservation

Introduction

Thomas R. Payne, located in Aurora, CO, is a prominent inventor recognized for his significant contributions to immunotherapy and cell preservation. With two patents to his name, his work focuses on enhancing treatments for T cell exhaustion and optimizing methods for cryopreservation of immune cells.

Latest Patents

Among Thomas's latest patents, one highlights **compositions and methods for treating T cell exhaustion**. This invention includes the administration of a PTD-MYC fusion protein, specifically an HIV TAT-MYC fusion protein, to subjects experiencing T cell exhaustion. Additionally, it emphasizes the provision of kits that aid in the application of these methods.

His second patent addresses **compositions and methods for the cryopreservation of immune cells**. This involves the pre-treatment of peripheral blood mononuclear cells (PBMCs) using a PTD-MYC fusion protein prior to freezing, ensuring the viability and functionality of these cells post-thaw. Kits designed for implementing this cryopreservation technique are also included in the patent.

Career Highlights

Thomas currently works at Htyr Acquisition LLC, where he collaborates on projects related to cell therapy and immunological advancements. His work is pivotal in pushing the boundaries of how immune responses are enhanced and managed, particularly for individuals facing immune challenges.

Collaborations

Thomas R. Payne collaborates with esteemed colleagues, including Yosef Refaeli and Brian C. Turner. Together, they leverage their expertise to bring innovative solutions to the field of immunology, advancing research and therapeutic applications.

Conclusion

Thomas R. Payne exemplifies how innovation in the field of immunotherapy can transform medical practices. With his groundbreaking patents, he continues to contribute valuable advancements that improve treatments for T cell exhaustion and enhance the preservation of immune cells. His ongoing collaborations signify a commitment to advancing science for the benefit of patients and the healthcare community.